Literature DB >> 12435286

Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging.

Ralph Naumann1, Bettina Beuthien-Baumann, Rainer Fischer, Thomas Kittner, Jan Bredow, Joachim Kropp, Detlef Ockert, Gerhard Ehninger.   

Abstract

Positron emission tomography (PET) with [18F]fluorodeoxyglucose [18F]FDG has evolved as a method of increasingly clinical importance in the management of patients with malignant lymphoma. However, inflammatory lesions also accumulate [18F]FDG and may cause difficulties with interpretation. This report deals with 2 patients with simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma, a rare but known coincidence of diseases. In the first case, Hodgkin's disease could not be differentiated from eosinophilic granuloma. Positron emission tomography showed increased [18F]FDG uptake both in lymphoma manifestations and in the granuloma. In the second case with proven Hodgkin's disease, post-treatment examination showed a positive PET lesion in the mediastinal residual mass, which was interpreted as viable lymphoma. However, histologic examination revealed that it was an eosinophilic granuloma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435286     DOI: 10.3816/clm.2002.n.019

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN: 1526-9655


  10 in total

1.  Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of 18F-FDG accumulation in the distal oesophagus.

Authors:  Lucia Rampin; Cristina Nanni; Stefano Fanti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08       Impact factor: 9.236

2.  18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis.

Authors:  Julie Obert; Laetitia Vercellino; Axel Van Der Gucht; Constance de Margerie-Mellon; Emmanuelle Bugnet; Sylvie Chevret; Gwenaël Lorillon; Abdellatif Tazi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-20       Impact factor: 9.236

3.  A case of coexisting Warthin tumor and langerhans cell histiocytosis associated with necrosis, eosinophilic abscesses and a granulomatous reaction in intraparotid lymph nodes.

Authors:  Char Loo Tan; Gangaraju Changal Raju; Fredrik Petersson
Journal:  Rare Tumors       Date:  2011-04-04

4.  Langerhans cell histiocytosis following Hodgkin lymphoma: a case report from Iran.

Authors:  Nahid Reisi Dehkordi; Parvin Rajabi; Azar Naimi; Mitra Heidarpour
Journal:  J Res Med Sci       Date:  2010-01       Impact factor: 1.852

Review 5.  Multiple metastasis-like bone lesions in scintigraphic imaging.

Authors:  Ying Zhang; Chunlei Zhao; Hongbiao Liu; Haifeng Hou; Hong Zhang
Journal:  J Biomed Biotechnol       Date:  2012-03-15

6.  Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma.

Authors:  R Naumann; B Beuthien-Baumann; A Reiss; J Schulze; A Hänel; J Bredow; G Kühnel; J Kropp; M Hänel; M Laniado; J Kotzerke; G Ehninger
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

7.  False Positive F-18 FDG PET/CT of Skeletal Metastasis Due to Solitary Eosinophilic Granuloma.

Authors:  Robert Mansberg; Bao Ho; Chuong Bui; Cathie Crombie
Journal:  Mol Imaging Radionucl Ther       Date:  2013-12-10

8.  Synchronously diagnosed eosinophilic granuloma and Hodgkin's disease in a 12-year-old boy: a case report.

Authors:  Soheila Sarmadi; Amir B Heidari; Amir H Sina; Mohammad A Ehsani
Journal:  J Med Case Rep       Date:  2009-01-29

9.  A case of Langerhans' cell histiocytosis following Hodgkin's disease.

Authors:  Xin Li; Q I Deng; Yu-Ming Li
Journal:  Mol Clin Oncol       Date:  2016-04-19

10.  Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.

Authors:  Alexandar Tzankov; Markus Kremer; Roos Leguit; Attilio Orazi; Jon van der Walt; Umberto Gianelli; Konnie M Hebeda
Journal:  Ann Hematol       Date:  2018-08-06       Impact factor: 3.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.